Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for GVHD prophylaxis in HLA-matched HSCT
NCT01491958Phase 2Completed
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Dec 2011
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in graft-versus-host disease (GVHD), sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Started Dec 2011; status: completed.
02
Drugs
atorvastatin
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT01491958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01491958.